
Opinion|Videos|December 21, 2023
Enfortumab Vedotin and the Role of ADCs in Bladder Cancer
Bladder cancer specialists discuss enfortumab vedotin and the role of antibody-drug conjugates in the treatment landscape.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC
3
Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy
4
Permanent J code for mitomycin for intravesical solution now in effect
5




















